A poll from the health policy nonprofit KFF found that 1 in 8 adults say they’ve taken a GLP-1 agonist, the obesity and ...
Still, affordability remains a challenge. Adults with annual household incomes of $90,000 or greater were more likely than ...
About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them – about 6% of adults, or more than 15 million people – are ...
JUST 6% OF US ADULTS WITH DIABETES AND OBESITY ARE TAKING THESE DRUGS ... AND THOSE WHO CAN GET ACCESS TO THE DRUG SOMETIMES HAVE TO STOP BECAUSE OF About 1 in 8 adults in the United States has used a ...
JUST 6% OF US ADULTS WITH DIABETES ... AND THOSE WHO CAN GET ACCESS TO THE DRUG SOMETIMES HAVE TO STOP BECAUSE OF About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic ...